Amcyte Diabetes Inc - CA Los Angeles, Santa Monica 90404

Amcyte Diabetes Inc entered the industry of Medical Research in 1991 and has grown to employ 1 to 4 people, generating an annual revenue of $2.500.000 to $4.999.999. The NAICS classifies this business under the code 541720, which describes it as a Medical Research. For further clarification, the SIC classifies this business under the code 8733 and described it as a Medical Research. The business provides service to the B2B market.

To acquire more information, please contact Terrence Son Shoung by calling No number given during business hours. You can also write to the business’ Single Location at 2825 Santa Monica Boulevard # 200, Santa Monica, California CA 90404. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Amcyte Diabetes Inc
Representative: Terrence Son Shoung
Place of Business: 2825 Santa Monica Boulevard # 200, Santa Monica, CA 90404
Contact Number: No number given
Type of Service: Medical Research
SIC Number: 8733
NAICS Number: 541720
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 1991
Income/Year: $2.500.000 to $4.999.999
Laborers: 1 to 4
Share This Company:

Amcyte Diabetes Inc is a company operating from Los Angeles, California providing professional Medical Research and relevant B2B variables. It was founded in 1991 and registered with the SIC code 8733 as Medical Research, and with the NAICS code 541720 as Medical Research.

With a current employee count of 1 to 4, Amcyte Diabetes Inc has gone to report making $2.500.000 to $4.999.999 per annum on its journey towards growth. This company invites you to contact its representative Terrence Son Shoung at No number given for related queries, or to locate its Single Location using the coordinates .

The Single Location can also be found at the street address 2825 Santa Monica Boulevard # 200 in Santa Monica, California 90404 and can be engaged online through the company website at , the company Twitter , and Facebook page .